Propranolol as a novel addition to anti-Kaposi sarcoma armamentarium: a hypothesis.

Suppr

超能文献

作者信息

Feily Amir, Pazyar Nader, Namazi Mohammad R

出版信息

Skinmed. 2011 Nov-Dec;9(6):391.

PMID:22256631

Abstract

摘要

相似文献

Propranolol as a novel addition to anti-Kaposi sarcoma armamentarium: a hypothesis.

Skinmed. 2011 Nov-Dec;9(6):391.

Topical timolol for Kaposi sarcoma: An innovation.

Australas J Dermatol. 2018 Nov;59(4):340-341. doi: 10.1111/ajd.12817. Epub 2018 Apr 6.

Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma.

Int J Dermatol. 2021 May;60(5):631-633. doi: 10.1111/ijd.15407. Epub 2021 Jan 7.

Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel.

J Am Acad Dermatol. 2017 Jan;76(1):153-155. doi: 10.1016/j.jaad.2016.08.041.

Medical management of vascular anomalies.

Facial Plast Surg. 2012 Dec;28(6):575-83. doi: 10.1055/s-0032-1329932. Epub 2012 Nov 27.

Propranolol for orbital hemangioma.

Ophthalmology. 2010 Jan;117(1):195-195.e4. doi: 10.1016/j.ophtha.2009.08.040.

Propranolol for treatment of ulcerated infantile hemangiomas.

J Am Acad Dermatol. 2011 May;64(5):827-32. doi: 10.1016/j.jaad.2010.12.040. Epub 2011 Feb 25.

Treatment With Oral Propranolol for Refractory Classic Cutaneous Kaposi Sarcoma.

JAMA Dermatol. 2022 Jul 1;158(7):832-834. doi: 10.1001/jamadermatol.2022.1278.

Treatment of cutaneous iatrogenic Kaposi sarcoma with topical timolol.

Australas J Dermatol. 2017 Aug;58(3):242-243. doi: 10.1111/ajd.12650.

Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.

J Pediatr Hematol Oncol. 2011 May;33(4):e171-3. doi: 10.1097/MPH.0b013e3182152e4e.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Propranolol as a novel addition to anti-Kaposi sarcoma armamentarium: a hypothesis.

Skinmed. 2011 Nov-Dec;9(6):391.

Topical timolol for Kaposi sarcoma: An innovation.

Australas J Dermatol. 2018 Nov;59(4):340-341. doi: 10.1111/ajd.12817. Epub 2018 Apr 6.

Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma.

Int J Dermatol. 2021 May;60(5):631-633. doi: 10.1111/ijd.15407. Epub 2021 Jan 7.

Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel.

J Am Acad Dermatol. 2017 Jan;76(1):153-155. doi: 10.1016/j.jaad.2016.08.041.

Medical management of vascular anomalies.

Facial Plast Surg. 2012 Dec;28(6):575-83. doi: 10.1055/s-0032-1329932. Epub 2012 Nov 27.

Propranolol for orbital hemangioma.

Ophthalmology. 2010 Jan;117(1):195-195.e4. doi: 10.1016/j.ophtha.2009.08.040.

Propranolol for treatment of ulcerated infantile hemangiomas.

J Am Acad Dermatol. 2011 May;64(5):827-32. doi: 10.1016/j.jaad.2010.12.040. Epub 2011 Feb 25.

Treatment With Oral Propranolol for Refractory Classic Cutaneous Kaposi Sarcoma.

JAMA Dermatol. 2022 Jul 1;158(7):832-834. doi: 10.1001/jamadermatol.2022.1278.

Treatment of cutaneous iatrogenic Kaposi sarcoma with topical timolol.

Australas J Dermatol. 2017 Aug;58(3):242-243. doi: 10.1111/ajd.12650.

Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.

J Pediatr Hematol Oncol. 2011 May;33(4):e171-3. doi: 10.1097/MPH.0b013e3182152e4e.